/enri-thumbnails/careeropportunities1f0caf1c-a12d-479c-be7c-3c04e085c617.tmb-mega-menu.jpg?Culture=en&sfvrsn=d7261e3b_1)
/cradle-thumbnails/research-capabilities1516d0ba63aa44f0b4ee77a8c05263b2.tmb-mega-menu.jpg?Culture=en&sfvrsn=1bc94f8_1)
Research Overview
As a research-intensive university, NTU has a vibrant research culture and environment. It has established a global reputation in fields such as biomedical engineering, clean energy, advanced materials and environment, intelligent systems, and nanotechnology.
To consolidate and further advance our research standing and capabilities, NTU College of Science (CoS) has identified niche areas of research and innovation strength; and actively facilitating and encouraging interdisciplinary and multidisciplinary research, recruiting and retaining talents, and strengthening partnerships with world leading institutions and industry partners.
.png?sfvrsn=539b34ee_0)
.jpg?sfvrsn=ec60fd14_0 "VVS-NTU_SPMS_Day2-8990(LO)")
School of Chemistry, Chemical Engineering and Biotechnology
CCEB conducts research into a broad spectrum of topics in chemistry, chemical engineering, food science, biomedical technology, and other fields. Our facilities are equipped with state-of-the-art equipment, which are also available for use by other researchers in NTU and elsewhere. We are constantly striving to maintain an intellectually stimulating environment to foster world-class research.
Research News & Highlights
Putting a New Spin on Digital Bits
Physicists at NTU SPMS have shown how information can be encoded robustly using electron spins in perovskite nanocrystals, forming a potential replacement for conventional electronics.
Read more
Coastal habitats face destruction in 30 years from rising sea levels
A team of international scientists led by NTU Singapore and Macquarie University in Australia has found that rising seas will once again devastate coastal habitats within the next 30 years, based on analysis of data on sea levels since the last Ice Age.
Read more
Repurposing the anti-cancer drug ponatinib
A team of scientists from the NTU School of Biological Sciences have found that ponatinib, a drug approved by the US Food and Drug Administration (FDA) for the treatment of chronic myeloid leukaemia, has shown exceptional promise in stopping the growth of ALT-dependent cancerous cells.
Read more